Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2023 Mar 1;14:1169734. doi: 10.3389/fphar.2023.1169734

Corrigendum: Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1

Junyu Han 1, Ziguan Zhang 1, Zhonghe Zhang 1, Shuyu Yang 2,*
PMCID: PMC10015591  PMID: 36937868

In the published article, there was an error in Figure 6 as published. The corrected Figure 6 and its caption appear below.

FIGURE 6.

FIGURE 6

ARS suppresses myocardial I/R injury through regulating miR-29b-3p/HMCN1 in vivo.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES